Canaan Partners

Founded in 1987, Canaan Partners is a global venture capital firm based in Menlo Park, California. With over $5 billion under management, the firm invests in early-stage technology and healthcare companies worldwide.

Brent Ahrens

General Partner

Nandu Anilal

Investor

John Balen

General Partner

Joydeep Bhattacharyya

General Partner

Stephen Bloch

General Partner

Laura Chau

General Partner - East Coast

Colleen Cuffaro

Partner

Brendan Dickinson

General Partner

Peter Farina

Investor

Rayfe Gaspar-Asaoka

Partner

Julie Grant

General Partner

Stephen Green

Venture Partner

Wende Hutton

General Partner

Maha Ibrahim

General Partner

Deepak Kamra

General Partner

Nina Kjellson

General Partner

Ehud Levy

Co-Founder and General Partner, Canaan Partners Israel

Mark Mangiola

Venture Partner

Jared Newman

Investor

John Pacifico

General Partner

Julie Papanek

Partner

Hootan Rashidifard

Principal

Guy Russo

General Partner

Uwe Schoenbeck

Venture Partner

Tim Shannon

General Partner

Hrach Simonian

General Partner

Dana Warren

Venture Partner, East Coast

Bob Williams

Venture Partner

Eric Young

Partner

Past deals in Series B

Cynomi

Series B in 2025
Cynomi is a London-based company founded in 2021 that specializes in providing scalable virtual Chief Information Security Officer (vCISO) services through its AI-powered platform. The platform enables managed security service providers (MSSPs) and consulting firms to deliver comprehensive vCISO services without the need to expand their current resources. Cynomi's multi-tenant architecture automates the generation of essential vCISO deliverables, including risk and compliance assessments, customized security policies, actionable remediation plans, and task management tools. It conducts a thorough analysis of a company's cybersecurity posture, producing detailed and prioritized remediation strategies that are continuously updated. This approach facilitates optimal security and regulatory compliance for organizations, ensuring they remain protected in an evolving cyber landscape.

AttoTude

Series B in 2025
AttoTude is a technology company specializing in the development of advanced interconnect solutions for AI and hyperscale data centers. It aims to surpass the limitations of existing data networking systems by creating innovative technology that significantly boosts bandwidth, enhances reliability, and reduces power consumption and costs.

Halda Therapeutics

Series B in 2024
Halda Therapeutics is a research-stage drug discovery company dedicated to developing next-generation precision medicine. The company employs a unique therapeutic modality that serves as a platform for addressing various disease states. By focusing on the discovery of novel therapies that modify disease-causing pathways, Halda Therapeutics aims to enable healthcare providers to offer more targeted treatments for their patients. Through its innovative approach, the company seeks to advance the field of precision medicine and improve patient outcomes.

Greywolf Therapeutics

Series B in 2024
Grey Wolf Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing innovative immunotherapies for oncology. Founded in 2017, the company aims to enhance the visibility of non-responsive tumors to the immune system by directly modifying tumor cells. Its approach involves targeting endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 within the antigen presentation pathway, which increases the neoantigen repertoire on tumor cells. This strategy is designed to improve the effectiveness of immunotherapy in treating cancer. Grey Wolf collaborates with leading academic and commercial partners to advance its drug discovery initiatives and deliver clinical candidates against well-validated targets in the field of immuno-oncology.

Nivoda

Series B in 2024
Founded in 2017, Nivoda operates a B2B online marketplace for buying and selling diamonds and jewelry. It simplifies global trade by offering an all-in-one solution for partners, ensuring reliable sourcing and competitive pricing.

Quantum Circuits

Venture Round in 2024
Founded in 2015 by Dr. Robert Schoelkopf, Quantum Circuits develops and manufactures quantum computers based on superconducting devices. The company focuses on creating full-stack quantum computers designed for efficient scaling, with a pioneering approach to error detection and correction.

Qlaris Bio

Series B in 2024
Qlaris Bio is a clinical-stage biotechnology company based in Wellesley, Massachusetts, founded in 2017. The company specializes in developing innovative therapies for serious and debilitating ophthalmic diseases, with a focus on addressing episcleral venous pressure (EVP), a significant component of intraocular pressure (IOP). Qlaris Bio's lead therapy, QLS-101, aims to reduce IOP, thereby mitigating the risk of blindness in conditions such as Primary Open Angle Glaucoma and Normal Tension Glaucoma. The company also targets other high unmet need conditions related to disturbances in intraocular pressure, including a progressive pediatric rare disease with limited effective therapies.

Pathios Therapeutics

Series B in 2024
Pathios Therapeutics is an early-stage biotech company based in Oxford, United Kingdom, focused on developing therapies for autoimmune diseases and cancer. Founded in 2017, the company specializes in creating small molecule inhibitors that target the pH-sensing G protein-coupled receptor GPR65. These inhibitors are designed to counteract the immunosuppressive effects of immune cells, such as tumor-associated macrophages, which are influenced by the acidic environment often found in tumors. By leveraging a deep scientific approach and human genetic insights, Pathios Therapeutics aims to generate novel therapeutics for advanced solid tumors and other unmet medical needs.

Alterome Therapeutics

Series B in 2024
Alterome Therapeutics is a precision oncology biotechnology company focused on developing alteration-specific therapeutics to target high-value, validated oncogenic drivers. It employs structure-guided drug discovery and advanced computational chemistry to create small-molecule therapies that selectively address oncogenic alterations, with the aim of improving patient outcomes in cancer.

Lily AI

Series B in 2024
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Nocion Therapeutics

Series B in 2024
Nocion Therapeutics is a biopharmaceutical company developing novel therapies called 'nocions' that selectively target actively firing nociceptors to provide relief for serious conditions such as cough, itch, pain, and inflammation.

Acesion Pharma

Series B in 2023
Founded in 2011, Acesion Pharma is a Danish biotech company dedicated to developing safe and tolerable treatments for atrial fibrillation (AF), the most common cardiac arrhythmia. The company focuses on inhibiting specific ion channels in heart cells to regulate the heart's rhythm and prevent AF recurrence.

Greywolf Therapeutics

Series B in 2023
Grey Wolf Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing innovative immunotherapies for oncology. Founded in 2017, the company aims to enhance the visibility of non-responsive tumors to the immune system by directly modifying tumor cells. Its approach involves targeting endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 within the antigen presentation pathway, which increases the neoantigen repertoire on tumor cells. This strategy is designed to improve the effectiveness of immunotherapy in treating cancer. Grey Wolf collaborates with leading academic and commercial partners to advance its drug discovery initiatives and deliver clinical candidates against well-validated targets in the field of immuno-oncology.

Appsmith

Series B in 2022
Appsmith is a company that specializes in open-source low-code software aimed at facilitating the rapid development of custom internal applications. Founded in mid-2019, Appsmith's platform allows developers to create, deploy, and manage applications with a focus on enterprise-grade security and governance. The software simplifies the development of internal tools, streamlining operations, automating processes, and enabling seamless integration of various applications and data sources. With over 5 million downloads and a user base that includes more than 1,000 enterprises across over 100 countries, Appsmith has established itself as a significant player in the low-code application development space, empowering developers to enhance legacy applications and build efficient internal web apps.

WorkMotion

Series B in 2022
WorkMotion is a global HR platform founded in 2020 and headquartered in Berlin, Germany. The company specializes in facilitating the hiring and onboarding of employees internationally, allowing organizations to recruit and manage remote workers from various countries with ease. Its cloud-based workforce management platform streamlines the hiring process by enabling employers to consolidate global payroll accounting and manage freelancers without the need to establish legal entities in foreign markets. By providing a comprehensive solution for international employment, WorkMotion supports businesses in expanding their talent acquisition capabilities across borders.

Lily AI

Venture Round in 2022
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Dusty Robotics

Series B in 2022
Dusty Robotics, Inc. is a technology company that specializes in automated layout services for the construction industry. Founded in 2018 and headquartered in Mountain View, California, the company has developed the FieldPrinter, a robotic tool that translates digital building information modeling (BIM) designs into accurate, on-site layouts. By integrating BIM information directly onto construction-site floors, Dusty Robotics eliminates manual processes, thereby enhancing efficiency in the construction workflow. The company's innovative solutions serve a diverse clientele, including owners, general contractors, subcontractors, and builders, helping them to reduce labor and material waste and improve the overall design-build-operate lifecycle.

Lev

Series B in 2022
Founded in 2019, Lev specializes in digitizing commercial real estate transactions via its technology platform. It offers financial services, including lending solutions and capital management.

BoostUp.ai

Series B in 2022
BoostUp.ai offers a sales intelligence platform that transforms unstructured data into actionable insights. Its solution analyzes risks at macro and micro levels, enhancing forecasting accuracy, efficiency, and predictability across the entire sales process. The company serves prominent clients such as Teradata, Degreed, and Iterable.

Hermeus

Series B in 2022
Hermeus Corporation, founded in 2018 and based in Atlanta, Georgia, is focused on developing hypersonic aircraft capable of flying at speeds exceeding Mach 5. These advanced jets significantly reduce travel times, allowing a flight from New York to London to take just 90 minutes instead of the typical seven hours. Hermeus aims to enhance the global transportation network by enabling businesses to operate efficiently without major changes to existing aviation infrastructure. The company's innovations not only decrease flight durations but also enhance safety for long-haul and business class air travel, facilitating improved connectivity between major global cities.

Taptap Send

Series B in 2021
Taptap Send is a mobile application that facilitates instant money transfers for immigrants sending funds back to Africa at low costs. Launched in the summer of 2018, the platform has successfully processed hundreds of millions of dollars and serves hundreds of thousands of customers. It operates in seven European countries and enables payments to various countries, including Ivory Coast, Senegal, Mali, Ghana, Guinea, Cameroon, Bangladesh, Kenya, Madagascar, Zambia, Vietnam, and the Democratic Republic of the Congo, with plans for further expansion. Taptap Send simplifies the remittance process by allowing users to transfer money directly to mobile money wallets using just a debit card, eliminating the need for physical deposits and saving time for its clients.

Apex.AI

Series B in 2021
Apex.AI develops software for autonomous mobility, offering a framework and tools that simplify the development of safe and secure autonomous driving applications. Its platform includes Apex.OS, which abstracts hardware, middleware, kernels, interfaces, and drivers into usable APIs, and Apex.Autonomy for safety-critical applications. It also offers MARV.Automotive, a data management platform that transfers vehicle data to the cloud, enables dynamic search-based analytics, analyzes partial logs, runs algorithms on real data, and provides graphical data introspection and team collaboration. Founded in 2017 and based in Palo Alto, California, Apex.AI builds on open-source software such as ROS and Eclipse iceoryx to provide building blocks for developers creating AI and safety-critical software for autonomous vehicles.

Edge Impulse

Series B in 2021
Edge Impulse is a software platform focused on simplifying the development of machine learning models optimized for edge devices, where data is collected. The platform streamlines the entire process, encompassing data acquisition, signal processing, machine learning training, model testing, and deployment. It enables developers to create intelligent applications by facilitating the collection of real sensor data and processing it from raw inputs to neural networks. Edge Impulse's technology supports a wide range of devices, allowing for efficient operation on various hardware from microcontrollers to GPUs. By enhancing the accessibility and efficiency of embedded machine learning applications, Edge Impulse aims to promote positive societal change through advanced technology.

Sounding Board Labs

Series B in 2021
Founded in 2016, Sounding Board Labs develops a platform that provides personalized coaching for leaders and new managers. Its platform offers executive coaching, connects through phone, video, and chat, creates development plans, and provides surveys and reporting to track progress.

Reibus

Series B in 2021
Reibus is an online marketplace designed for the buying and selling of metals, specifically targeting industrial markets. The company connects businesses with a network of metal suppliers, facilitating seamless transactions and logistics for metal transportation. Its platform includes features such as anonymous buying, real-time leads for sellers, and transparent shipping options. By providing a proprietary search tool and a streamlined materials listing process, Reibus aims to enhance price performance, minimize time to market, and expand market reach, ultimately reducing sales and marketing-related expenses for its users.

Clutch

Series B in 2021
Clutch is a technology company revolutionizing car buying, selling, and ownership. It offers high-quality certified vehicles through a seamless online customer experience, with inventory browsing, purchase completion, and effortless home delivery. Clutch aims to provide customers with a delightful car-buying journey while positively impacting communities.

TrueFort

Series B in 2021
TrueFort specializes in real-time application and cloud workload protection. Founded in 2015, the company offers solutions such as application-first security, out-of-box analytics for applications, and bring-your-own-agent capabilities. Its flagship product, Fortress, employs advanced behavioral analysis and automation to enhance security across diverse environments.

Kepler Communications

Series B in 2021
Kepler Communications designs, develops, and operates satellite networks for global connectivity. It specializes in Low-Earth Orbit (LEO) satellites, PolarConnect for extreme environments, Global Data Service for large data transfers, and everywhereIOT for IoT devices. Serving industries such as maritime, natural resources, research, defense, and logistics.

Archipelago

Series B in 2021
Archipelago Analytics, Inc., based in San Francisco, California, was incorporated in 2018 and specializes in utilizing artificial intelligence to enhance risk management for large commercial property owners. The company's platform digitizes risk data, facilitating improved insurance outcomes and overall resilience. By enabling the efficient movement of critical information through the insurance value chain—from clients to brokers and capacity providers—Archipelago aims to lower the total cost of risk for its users, ensuring they receive timely and relevant data to make informed decisions.

Tyra Biosciences

Series B in 2021
Tyra Biosciences is a biotechnology company focused on developing precision therapies for cancer. It uses its proprietary SNAP platform to create next-generation drug candidates that target acquired drug resistance, with an initial focus on the Fibroblast Growth Factor Receptor (FGFR) family.

Day One Biopharmaceuticals

Series B in 2021
Day One Biopharmaceuticals is a clinical-stage biotechnology company focused on developing targeted therapies for genetically defined cancers across all ages, with an initial emphasis on pediatric patients. The company aims to bring effective cancer treatments to families by advancing therapies that can benefit both children and adults, prioritizing programs that can progress to the market rapidly. Day One pursues licensing or acquisition of promising products from research institutions and industry partners to expand its pipeline. Its lead candidate, DAY101, is an oral, brain-penetrant, highly selective type II pan-RAF kinase inhibitor designed to target cancers driven by the RAF signaling pathway. By applying insights from childhood cancer biology, the company seeks to address unmet needs in oncology and broaden access to precision therapies.

Axis Security

Series B in 2020
Axis Security Inc. is a cybersecurity company founded in 2018 and based in Palo Alto, California. It specializes in Zero Trust Network Access solutions, providing a cloud security platform that ensures secure remote access to applications. The company's technology focuses on application isolation and employs a context-aware approach to security, evaluating multiple factors to ensure that only authorized users can access specific resources within a network. This business-centric strategy allows organizations to maintain control over sensitive information and manage access for employees, partners, and other stakeholders effectively.

Papa

Series B in 2020
Papa, Inc. operates an online platform designed to connect college students with senior citizens, facilitating various services to assist older adults in maintaining their independence and well-being. Founded in 2016 and based in Miami, Florida, the platform enables college and nursing students to provide companionship and assistance in areas such as transportation, house chores, technology lessons, grocery shopping, and caregiving. By connecting vetted companions with older adults, Papa aims to enhance social connections and support for seniors, allowing them to live securely and happily at home.

Instrumental

Series B in 2020
Instrumental, Inc. specializes in developing software solutions that enhance the efficiency of assembly lines, enabling them to operate autonomously while adapting to various parts and processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to reduce costs associated with scrap and rework by allowing manufacturers to identify and resolve issues on their assembly lines. Instrumental's technology has been deployed in multiple global assembly lines at leading manufacturers, helping to prevent delays in development schedules and start production at higher yields. In addition to its software offerings, Instrumental also provides services related to high-performance computing, data storage, and business continuity, catering to both commercial and government sectors. The firm is headquartered in Saint Paul, Minnesota, and has been operational since 1991.

READY Robotics

Series B in 2020
Founded in 2016, READY Robotics is headquartered in Columbus, Ohio. The company specializes in developing ForgeOS, an industrial operating system for robotics and automation. This patented technology enables manufacturers to deploy and manage robots efficiently using a standardized set of low-code apps, particularly beneficial for high-mix/low-volume manufacturing.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. is a technology company specializing in the development of artificial intelligence-driven robotic and automated material handling systems. Founded in 2013 and based in Lexington, Massachusetts, the company focuses on automating tasks traditionally performed by humans in commercial settings, enhancing efficiency in fulfillment, supply chain, and logistics operations. Its offerings include a range of robotic solutions, such as autonomous picking and sorting systems, mobile robotic units, and dynamic parcel sortation technologies. Additionally, Berkshire Grey provides electromechanical solutions that incorporate vision systems and advanced scanning technologies. By leveraging AI, computer vision, and machine learning, the company's systems enable clients to achieve higher accuracy and throughput speeds while managing diverse product assortments. The majority of its revenue is generated from North America, positioning Berkshire Grey as a significant player in the automation landscape.

Capella Space

Series B in 2019
Capella Space is an information services company based in San Francisco that operates a constellation of small satellites equipped with synthetic aperture radar, delivering on-demand, high-resolution radar imagery of the Earth's surface. The SAR imagery can be acquired through clouds, smoke, fog, and darkness, enabling continuous global monitoring and rapid insight across industries. Capella's services support infrastructure monitoring, agriculture, disaster response, maritime domain awareness, city planning and mapping, and business intelligence, helping customers detect sub-meter surface changes, track economic activity, and monitor environmental and security-related conditions. Founded in 2016, Capella Space provides timely earth observation for commerce, conservation, and safety.

nTopology

Series B in 2019
nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

CompStak

Series B in 2019
CompStak, Inc., founded in 2011 and headquartered in New York, operates an online platform that provides a comprehensive database of commercial lease comparables. Utilizing a crowd-sourced model, CompStak facilitates the exchange of detailed lease information, which includes tenant names, addresses, rental rates, square footage, landlord concessions, broker identities, and other pertinent data. This information is critical for real estate investors, brokers, asset managers, and appraisers as they conduct valuations and analyses of commercial properties. CompStak's platform serves various stakeholders in the real estate market, enabling informed decision-making in significant investments and property comparisons. Additionally, CompStak has established a strategic partnership with Knowledge Cubed to enhance its data offerings, further solidifying its position in the industry.

Gen.G esports

Series B in 2019
Gen.G esports is a prominent professional esports organization founded in 2017, with its headquarters in Seoul, South Korea, and additional offices in Los Angeles and Shanghai. The organization is known for bridging the esports markets in the United States and Asia, operating top teams in renowned games like Overwatch and League of Legends, and featuring a celebrated all-female Fortnite team. Gen.G has achieved significant recognition, including being ranked among the world's most valuable esports companies. Its teams have won seven global championships, reflecting their competitive prowess. Beyond team management, Gen.G offers a range of services such as coaching, training, and business development, while also creating platforms for global brands to engage with gaming fans. The company is committed to fostering inclusivity in esports through initiatives like #TeamBumble and the Gen.G Elite Esports Academy, which integrates academic programs with esports training. Gen.G's mission emphasizes leveraging the power of gaming to empower both fans and athletes in their pursuits, establishing it as a leader in the evolving landscape of sports entertainment.

Roman

Series B in 2019
Roman is a men's health company that offers online diagnosis and discreet shipping of safe erectile dysfunctional medication. The company was launched in 2017 as a vertical of Ro, a healthcare technology company.

ScaleFactor

Series B in 2019
ScaleFactor provides automated accounting and finance software, offering features such as bookkeeping automation, proactive alerts, and business insights translation. It formerly offered additional services like IT integration, HR/payroll, compliance, and CFO advisory. ScaleFactor served various industries including professional services, restaurants, retail, technology, and wellness. The company was founded in 2014 and had offices across North America before ceasing operations.

Embroker

Series B in 2018
Embroker, Inc. is a digital insurance brokerage that specializes in providing insurance services to small and mid-sized businesses. Founded in 2015 and headquartered in San Francisco, with additional offices in Chicago, Boston, Denver, and New York, Embroker utilizes an online platform to streamline the process of purchasing, managing, and analyzing commercial insurance policies. The platform allows clients to automate the sharing, requesting, and tracking of proof of coverage, as well as monitor claims in real-time. Embroker offers a wide range of insurance products, including Commercial General Liability, property insurance, professional liability, and employee benefits, among others. The company also provides tools for peer comparison, enabling clients to benchmark their policies against industry standards. By combining technology with broker expertise, Embroker aims to enhance the efficiency and effectiveness of the $800 billion property and casualty insurance market, helping businesses save time and secure optimal coverage.

Dragos

Series B in 2018
Dragos is an industrial cybersecurity company dedicated to protecting the world's critical infrastructure. Its platform offers visibility into industrial control systems (ICS) and operational technology (OT) networks, enabling early threat detection and mitigation.

OncoResponse

Series B in 2018
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

Cargomatic

Series B in 2018
Cargomatic, Inc. is a technology-driven transportation platform that connects shippers with pre-screened carriers in real-time, primarily serving the short-haul and drayage trucking markets. Founded in 2013 and headquartered in Venice, California, Cargomatic facilitates an on-demand network for local truck availability, allowing shippers to submit loads and quickly find nearby trucks to meet their logistics needs. Since its launch in early 2014, the company has successfully supported tens of thousands of deliveries across California, Chicago, and metropolitan New York. By streamlining communication and reducing the reliance on traditional booking methods, Cargomatic enhances service levels, improves pick-up times and delivery rates, and enables customers to manage their outsourced transportation vendors more effectively through a single platform.

Kustomer

Series B in 2018
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

PACT Pharma

Series B in 2018
PACT Pharma, Inc. is a biotechnology company focused on developing personalized cell-based therapies for cancer treatment. The company specializes in neoantigen-specific adoptive T-cell therapies aimed at solid tumors. Its innovative platform utilizes bioinformatics to analyze patients' tumor and normal DNA and RNA, identifying candidate neoantigen peptides that stimulate robust antitumor T-cell responses. By pinpointing neo-epitopes unique to each patient's cancer, PACT Pharma enables the engineering of autologous T cells that specifically target and eradicate tumors expressing these neo-antigens. Founded in 2016 and headquartered in South San Francisco, California, PACT Pharma is dedicated to advancing personalized medicine in oncology.

Mynd

Series B in 2018
Mynd is a tech-enabled property management firm specializing in single-family rental properties. It offers comprehensive solutions including marketing, tenant screening, rent collection, maintenance, accounting, and data-driven insights to optimize property performance and maximize returns for clients.

Vineti

Series B in 2018
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

IDEAYA Biosciences

Series B in 2018
IDEAYA Biosciences is an oncology-focused biotechnology company dedicated to discovering targeted therapeutics for patient populations selected using molecular diagnostics. Its pipeline includes small molecule inhibitors targeting DNA damage and repair pathways, such as MAT2A, PARG, and Pol-theta, as well as immuno-oncology therapies targeting the tumor microenvironment.

Imanis Data

Series B in 2018
Imanis Data is a San Jose-based company that specializes in subscription-based data availability management solutions for enterprise-scale environments. Founded in 2012 and formerly known as Talena, the company offers two primary products: FastFind, a metadata catalog that simplifies Big Data application management across various platforms, and Imanis Data 3.0, a backup and recovery platform designed to detect ransomware attacks early and prevent accidental data loss. These solutions are architected for petabyte-scale datasets and leverage machine learning to minimize risk and reduce costs. As of May 2019, Imanis Data operates as a subsidiary of Cohesity, Inc.

Contentsquare

Series B in 2018
ContentSquare is a digital experience insights optimization platform that helps businesses analyze customer behavior through vast amounts of anonymous web, mobile, and app interactions, adhering to data privacy regulations such as the EU GDPR and California CCPA. By integrating diverse data sets, including content, user experience, product offerings, pricing, acquisition channels, and technical performance, the platform generates insights and AI-driven recommendations to enhance digital performance throughout the customer journey. Its solutions enable clients to better understand user interactions, measure content effectiveness, and clarify consumer intentions, ultimately leading to increased revenue and engagement while reducing operational costs. ContentSquare serves over 700 enterprise clients, including notable brands like American Express, Best Buy, and LVMH.

Ladder

Series B in 2018
Ladder is a digital life insurance company founded in 2015. It offers flexible term coverage up to $8M across all U.S. states, with an all-digital application process and real-time underwriting, aiming to make life insurance more accessible and affordable.

MindTickle

Series B in 2017
MindTickle offers a sales readiness platform that enables companies to train, coach, and align their customer-facing teams. Its data-driven approach combines on-demand training, mobile updates, gamification, coaching, role-play, and assessment tools to enhance sales performance. Headquartered in San Francisco and Pune, MindTickle is privately held.

PerimeterX

Series B in 2017
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

Vivace Therapeutics

Series B in 2017
Founded in 2014, Vivace Therapeutics is a biotechnology company based in the San Francisco Bay Area. It focuses on discovering and developing cancer therapeutics by targeting novel pathways, with a particular emphasis on the Hippo pathway which controls tissue regeneration and organ size.

Iterum Therapeutics

Series B in 2017
Iterum Therapeutics is a clinical-stage pharmaceutical company focused on developing novel anti-infectives to combat multi-drug resistant pathogens. Its lead product, sulopenem, is a penem antibiotic with both oral and intravenous formulations, currently in Phase III trials for treating various urinary tract infections and intra-abdominal infections.

Onkos Surgical

Series B in 2017
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

UNIFi Software

Series B in 2017
Unifi Software, Inc. develops a suite of self-service data integration tools designed for both business users and IT professionals. Its flagship products include the Unifi catalog, which utilizes AI technology for data crawling and asset collection, allowing users to identify and process critical data assets. This catalog supports user-friendly search, collaboration, and data governance for enhanced security. Additionally, the Unifi data platform facilitates data acquisition, discovery, enrichment, transformation, normalization, and formatting, while also handling unstructured data. IT professionals benefit from features that enable connection to data sources, user authorization, and resource management. The platform is accessible through the Microsoft Azure Marketplace and offers solutions for various applications, including audience analytics and cloud migration. Founded in 2013 and based in San Mateo, California, Unifi Software operates as a subsidiary of Boomi, Inc.

Apartment List

Series B in 2016
Apartment List is an online rental marketplace in the United States that connects renters with landlords. The platform offers a search experience with details on prices, locations, and amenities through web and mobile interfaces. The company emphasizes a fair, transparent, and simple renting process and provides a personalized search that learns user preferences to streamline finding suitable apartments. Based in San Francisco, it serves tenants and property owners by helping users discover listings and make informed decisions, reducing time and hassle in the search. Established in the late 2000s, Apartment List aims to make the home-finding process more personal, flexible, and efficient.

Chrono Therapeutics

Series B in 2016
Chrono Therapeutics Inc. is a pharmaceutical company based in Hayward, California, focused on revolutionizing drug delivery and addiction management. Founded in 2003, the company specializes in the development of SmartStop, a digital nicotine replacement therapy that employs a wearable device to deliver programmable, transdermal drug therapy. This innovative system is designed to tailor the timing and dosage of nicotine while providing real-time behavioral support to help users manage addiction and smoking cessation effectively. Chrono Therapeutics aims to address the challenges associated with smoking addiction through its advanced technology, which seeks to achieve optimal clinical outcomes and improve the overall quality of life for users. The company's leadership team brings extensive experience in product development, research and development, and navigating regulatory pathways, positioning Chrono Therapeutics as a key player in the smoking cessation market.

Rocketrip

Series B in 2016
Rocketrip, Inc. is a travel management platform founded in 2013 and based in New York, New York. The company focuses on enabling employees to make cost-effective travel decisions while earning rewards for saving on expenses. Its platform provides real-time insights into reasonable travel spending, allowing users to compare costs and choose lower-priced options for flights, cars, and hotels without disrupting their online booking process. By establishing a custom-calibrated budget known as the Price to Beat, Rocketrip incentivizes employees to select economical travel arrangements, thereby promoting a culture of cost savings within organizations. The platform is utilized by several enterprise brands, demonstrating its effectiveness in the corporate travel sector. As of September 2020, Rocketrip operates as a subsidiary of Mondee Holdings Inc.

World View

Series B in 2016
World View Enterprises, Inc., established in 2012 and headquartered in Tucson, Arizona, specializes in space travel services for research, education, and scientific purposes. The company pioneers the exploration of the stratosphere, offering stratospheric remote sensing services and space tourism experiences. World View's innovative, patented technology enables long-duration, high-resolution data collection and affordable alternatives to traditional imagery providers. With over 115 successful stratospheric flights and 10,274,598 vertical feet flown, the company has earned the trust of NASA and other organizations, providing meaningful space tourism and valuable data services to both public and private sectors.

Tizona Therapeutics

Series B in 2016
Founded in 2014, Tizona Therapeutics is a biopharmaceutical company based in South San Francisco, California. It specializes in developing immunotherapies for cancer and autoimmune diseases, with a focus on understanding the role of regulatory T cells in various tumors.

Unchained Labs

Series B in 2016
Unchained Labs is a life sciences tools company based in Pleasanton, California, specializing in solutions for biologics and gene therapy researchers. Established in 2014, it develops a range of products designed to enhance the efficiency and effectiveness of research in protein stability and formulation. Key offerings include the Optim platform, which allows researchers to measure multiple protein stability parameters simultaneously, and GRUNT, an automated system for biologic formulation preparation. In addition to these, the company provides various tools such as protein sizing systems, stability quantifiers, and automated buffer exchange systems. Unchained Labs serves biopharma and academic customers globally, distributing its products through partnerships in Europe, North and South America, Japan, and other Asian markets.

Bellhops

Series B in 2015
Bellhops, Inc. is a U.S. moving services company that provides loading and unloading for trucks, trailers, storage units, and mobile storage containers, along with heavy lifting. It operates via an online platform and mobile applications that connect customers with movers, enabling local and short- to mid-distance moves for households and businesses. The company emphasizes a technology-enabled model to improve customer experience and pricing transparency, offering booking through a self-service dashboard and a team of movers. Founded in 2013 and based in Chattanooga, Tennessee, Bellhops serves customers across numerous U.S. cities, focusing on small and medium-scale moves and expanding its geographic footprint.

Arvinas

Series B in 2015
Arvinas, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, that specializes in the discovery, development, and commercialization of innovative therapies aimed at degrading disease-causing proteins. The company's lead product candidates include ARV-110, a proteolysis targeting chimera (PROTAC) currently in phase I clinical trials for metastatic castration-resistant prostate cancer, and ARV-471, which targets the estrogen receptor for patients with metastatic ER-positive/HER2-negative breast cancer. In addition to these, Arvinas is developing various other PROTACs aimed at degrading clinically relevant androgen receptor mutations and treatments for neurodegenerative diseases, including tauopathies. The company has established collaborations with prominent pharmaceutical firms such as Pfizer Inc., Genentech, and Bayer AG, enhancing its research capabilities and reach within the biopharmaceutical landscape. Founded in 2015, Arvinas aims to improve patient outcomes by eliminating harmful proteins from the body through its proprietary technology.

Antiva Biosciences

Series B in 2015
Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

RealtyMogul

Series B in 2015
RealtyMogul is an online marketplace designed to facilitate real estate investing by connecting individual and institutional investors with institutional-quality real estate opportunities. Founded in 2012 by Jilliene Helman and Justin Hughes, the company is headquartered in Los Angeles, California. The platform allows users to browse various real estate investments, access due diligence materials, and securely sign legal documents online. Investors benefit from a dedicated dashboard that provides 24/7 access to monitor their investments. RealtyMogul's model aims to simplify the real estate investment process, offering opportunities in well-leased properties while ensuring compliance through registered broker-dealers, thereby minimizing risk and streamlining the investment process.

Tubular Labs

Series B in 2015
Tubular Labs is a leading video measurement and analytics platform that serves broadcasters, publishers, and brands by providing insights into video consumption patterns. The platform tracks over 4 billion videos and 1 trillion views, analyzing a vast array of data that includes 10 million influencers and 90,000 brands. It offers a comprehensive view of the social video ecosystem, allowing businesses to create effective content and scale their audiences more rapidly. Tubular Labs delivers valuable ratings and context for digital video, helping companies refine their content strategies, enhance distribution, and optimize paid media campaigns. The platform is trusted by several top global media companies, who rely on its analytics to make informed strategic decisions in the dynamic landscape of video content.

Glooko

Series B in 2015
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Beckon

Series B in 2015
Beckon, Inc. is a software company specializing in omnichannel analytics for marketers, founded in 2011 and headquartered in San Mateo, California. It offers a software-as-a-service platform that integrates marketing data to provide performance analytics and visualization solutions. Beckon's software delivers real-time marketing intelligence through automated data management, allowing marketers to gain total visibility into cross-channel performance. The platform features pre-built dashboards, scorecards, and key performance indicators, enabling users to make informed decisions swiftly and maximize return on investment. As of November 2018, Beckon operates as a subsidiary of Aclate, Inc. Its goal is to aid marketers in organizing complex data and effectively demonstrating the impact of marketing efforts on business outcomes.

ALDEA Pharmaceuticals

Series B in 2014
ALDEA Pharmaceuticals, Inc. is a biotechnology company focused on developing small-molecule modulators of the aldehyde dehydrogenase (ALDH) enzyme superfamily. Founded in 2008 and headquartered in Redwood City, California, the company aims to address diseases associated with aldehyde metabolism dysfunction, which can range from acute alcohol toxicity to rare conditions such as Fanconi anemia. ALDEA's proprietary technology offers new product opportunities targeting a variety of therapeutic areas, including the development of ALDH activator compounds that enhance the detoxification of harmful aldehydes like acetaldehyde. These advancements are intended to alleviate acute symptoms and mitigate long-term tissue damage and cancer risk related to alcohol consumption and other toxic aldehyde-related diseases.

Turo

Series B in 2014
Turo Inc. is an online car rental marketplace that connects local car owners with travelers seeking to rent vehicles. Founded in 2009 and based in San Francisco, California, Turo allows users to list their cars for rent, offering options for local pickup, city delivery, and airport delivery. The platform provides a wide selection of vehicles at competitive prices, enabling car owners to earn income while providing convenient access to cars for renters. Turo facilitates a peer-to-peer car-sharing model, creating a vibrant community of trusted hosts and enhancing the travel experience for users. The company was formerly known as RelayRides, Inc. before rebranding in November 2015.

Instacart

Series B in 2014
Instacart operates a grocery delivery platform in the United States and Canada, partnering with local and national grocers to offer a broad catalog of items for home delivery. Customers can mix items from multiple stores in a single order, and orders are picked and delivered by shoppers who are typically independent contractors. The platform supports fast delivery, including options in as little as an hour. Instacart earns revenue from service fees based on order value and by selling advertising to consumer-packaged goods brands. The service catalogs about 500,000 items and attracts about 8 million monthly active users, supported by roughly 600,000 shoppers.

Metacloud

Series B in 2014
Metacloud is a cloud solutions company specializing in OpenStack-based private cloud services for enterprises. Founded in 2010 by experienced architects from leading web commerce and technology firms, Metacloud designs, deploys, and supports production-ready private clouds for Fortune 500 companies across various industries. The company operates on an OpenStack-as-a-Service model, which allows it to remotely manage and operate these private clouds within customers' data centers. Based in Pasadena, California, Metacloud is also a corporate sponsor of the OpenStack Foundation and actively contributes to the OpenStack community.

Tubular Labs

Series B in 2014
Tubular Labs is a leading video measurement and analytics platform that serves broadcasters, publishers, and brands by providing insights into video consumption patterns. The platform tracks over 4 billion videos and 1 trillion views, analyzing a vast array of data that includes 10 million influencers and 90,000 brands. It offers a comprehensive view of the social video ecosystem, allowing businesses to create effective content and scale their audiences more rapidly. Tubular Labs delivers valuable ratings and context for digital video, helping companies refine their content strategies, enhance distribution, and optimize paid media campaigns. The platform is trusted by several top global media companies, who rely on its analytics to make informed strategic decisions in the dynamic landscape of video content.

NatureBox

Series B in 2014
NatureBox is a California-based company established in 2011, specializing in the delivery of healthier snack options directly to consumers' doors. It offers a variety of non-GMO and vegan snacks such as dried fruits, nut mixes, cookies, bars, chips, crackers, and popcorn, catering to diverse dietary preferences. NatureBox operates an online platform that allows users to personalize their orders based on taste and dietary needs. With a customer base growing at a rate of 50-100% monthly, the company serves customers across all 50 states. In addition to its commercial operations, NatureBox is committed to social responsibility, partnering with WhyHunger to provide nutritious food to those in need and previously donating over 150,000 meals to Feeding America.

CircleUp

Series B in 2014
CircleUp is a San Francisco-based company established in 2012, operating an online platform that connects early-stage consumer and retail brands with accredited investors. The platform facilitates capital raising and provides resources to these companies, enabling them to grow and scale. CircleUp's proprietary machine learning platform, Helio, evaluates and predicts the potential success of over 1.3 million consumer businesses, aiding in the discovery and selection of promising investment opportunities.

UrbanSitter

Series B in 2014
Founded in 2010, UrbanSitter operates a childcare marketplace that connects parents with trusted babysitters and nannies recommended by people within their network. The platform also offers services for pet sitting, housekeeping, tutoring, and senior care. With a focus on convenience and reliability, UrbanSitter enables users to book caregivers at short notice.

SureWaves

Series B in 2014
SureWaves MediaTech Private Limited is a Bengaluru-based company that specializes in media convergence solutions, particularly in the realm of television advertising. Founded in 2006, the company offers Skynet, a programmatic advertising marketplace that allows marketers to plan and purchase audience segments on broadcast TV channels. Additionally, SureWaves operates the SureWaves Spot TV Network, which helps brands reach diverse audiences through local cable and regional satellite channels. The firm is led by a team of experienced professionals with backgrounds in media, marketing, and technology, and has developed the SureWaves Media Grid, an integrated platform for ad aggregation, content delivery, and media planning. This platform leverages cloud computing technologies for scalability and efficiency. SureWaves has filed over 40 patents related to its technology and has made significant inroads into the digital out-of-home market and local television advertising space, aiming to enhance the accessibility and measurability of advertising through advanced automation and artificial intelligence.

India Property Online

Series B in 2013
India Property Online Private Limited operates an online platform that facilitates the buying, selling, and renting of properties across India. Established in 2006 and headquartered in Chennai, the platform enables builders, landowners, and landlords to list their properties for potential buyers and renters. The service caters to clients in major cities including Chennai, Bengaluru, Mumbai, Hyderabad, Delhi, and others. India Property Online is associated with Consim Info Pvt. Ltd, a prominent internet company recognized for its diverse offerings in various sectors such as matrimonial services and classifieds. The company has also formed partnerships with leading media organizations to enhance customer service and improve visibility for property listings. As of December 2018, it operates as a subsidiary of Quikr India Private Limited.

Corvium

Series B in 2013
Corvium, Inc. is a food intelligence company that specializes in software solutions for food safety. Founded in 2009 and headquartered in Reston, Virginia, with an additional office in Boston, Massachusetts, Corvium offers its CONTROL-PRO platform, which streamlines the food safety testing lifecycle through visualization, monitoring, analytics, and documentation. This solution aims to reduce the risks of undetected contamination and recalls by minimizing manual tasks prone to errors. In conjunction with its INSIGHTS offering, Corvium provides tailored analysis and continuous monitoring of data flows, aggregating both internal and external information to enhance food safety performance across production facilities. The company's clientele includes food processors, retailers, and consumers, all benefiting from Corvium's commitment to ensuring the safety of food products through robust data management and superior customer service.

Sample6

Series B in 2013
Sample6 is a biotechnology company that specializes in the development of a synthetic-biology based diagnostic system for bacteria. Its innovative technology enables enrichment-free detection of harmful bacteria, identifying levels as low as 1 CFU/ml within just four hours. The proprietary Bioillumination Platform, created by a team of researchers including Professor Tim Lu from MIT, allows for the engineering of bioparticles that target specific unwanted bacteria, illuminating them for detection. This system is coupled with sensitive sensor technology that provides rapid on-site results without the need for a laboratory. Sample6 aims to enhance public health and safety by enabling quick and efficient detection of harmful bacteria across various industries, including food production, retail, and healthcare, addressing environments where humans and bacteria interact.

Civitas Therapeutics

Series B in 2013
Civitas Therapeutics is a biopharmaceutical company dedicated to the development and commercialization of innovative pulmonary delivery therapies aimed at treating central nervous system and respiratory disorders. Utilizing its proprietary ARCUS technology, Civitas aims to transform the therapeutic landscape for patients across the United States. The company's focus is on creating effective treatments that enhance patient outcomes and address unmet medical needs in these critical areas.

JOOR

Series B in 2013
JOOR operates a digital wholesale platform that connects fashion brands and retailers worldwide. The system replaces manual ordering with automated B2B order management, payment processing, and virtual showrooms, enabling faster transactions and reduced errors. It supplies data analytics to help users track performance, cut costs, and enhance customer experience. Through a curated network of global partners, the platform supports brands and buyers in building strategic relationships and scaling operations across markets.

Minimally invasive devices

Series B in 2013
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

Dermira

Series B in 2013
Dermira, Inc. is a biopharmaceutical company that specializes in developing and commercializing therapies for dermatologic diseases, primarily targeting the U.S. market. Founded in 2010 and headquartered in Menlo Park, California, Dermira offers QBREXZA, a topical treatment for primary axillary hyperhidrosis in patients aged nine and older. The company is also advancing its pipeline with lebrikizumab, a monoclonal antibody currently in Phase IIb trials for moderate-to-severe atopic dermatitis, alongside several other early-stage research initiatives in dermatology. Dermira has established strategic partnerships for the development and commercialization of its products, including agreements with Maruho Co., Ltd., F. Hoffmann-La Roche Ltd, Genentech, Inc., and UCB Pharma S.A. Notably, Dermira was previously known as Skintelligence, Inc. before rebranding in September 2011. As of early 2020, Dermira operates as a subsidiary of Eli Lilly and Company.

WibiData

Series B in 2013
WibiData is a software company that specializes in big data applications aimed at helping enterprises create personalized experiences across various channels. Founded in 2010 in San Francisco under the name Odiago by Christophe Bisciglia, Aaron Kimball, and Garrett Wu, WibiData leverages open-source technologies such as Apache Hadoop, Apache Cassandra, Apache HBase, Apache Avro, and the Kiji Project. The company is supported by several notable investors, including Canaan Partners and New Enterprise Associates. Through its innovative platform, WibiData enables organizations to effectively analyze and utilize their data for enhanced customer engagement.

The RealReal

Series B in 2013
The RealReal operates an online marketplace for authenticated luxury resale, offering fashion for women, men and kids, as well as jewelry, watches, art and home items. Founded in 2011 and headquartered in San Francisco, it functions as a full-service consignment platform that authenticates every item through in-house experts and uses technology to determine pricing, while managing photography, listings, payments and shipping. It is the largest pure-play luxury resale platform in the United States and supports a sustainable circular economy by facilitating resale across multiple categories. The company generates revenue primarily from consignments and first-party sales on its marketplace, with additional direct sales, and provides services such as virtual appointments, in-home pickup and direct shipping to buyers.

Minimally invasive devices

Series B in 2013
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

Theraclone Sciences

Series B in 2013
Theraclone Sciences, Inc. is a discovery-stage biotechnology company based in Seattle, Washington, focused on developing novel therapeutic antibodies for cancer and infectious diseases. The company employs its proprietary In-Situ Therapeutic Antibody Rescue technology to rapidly identify and test human antibodies with exceptional biological functions. Theraclone's pipeline includes TCN-032, a recombinant human monoclonal antibody aimed at treating patients hospitalized with severe influenza, along with several preclinical and clinical programs targeting unmet medical needs such as triple-negative breast cancer, infectious disease-associated cancers, and multidrug-resistant bacteria. Founded in 2004 and originally known as Spaltudaq Corporation until its rebranding in 2009, Theraclone leverages the natural immune responses of human subjects to discover rare monoclonal antibodies that could lead to effective therapeutic interventions.

Artspace

Series B in 2013
Artspace is a New York-based online retailer specializing in contemporary art, serving as a marketplace where collectors can purchase works directly from leading commercial galleries, prestigious cultural institutions, and non-profit organizations. The platform features a diverse range of artworks, including prints, photography, paintings, sculptures, and design items. Artspace also collaborates with renowned artists to commission exclusive limited editions, enhancing its offerings. The company aims to facilitate the discovery, education, and acquisition of art for both aspiring and experienced collectors, while simultaneously supporting artists and the institutions that promote their work. Many proceeds from the sales on the platform benefit these esteemed artists and organizations, broadening their reach to a global audience.

ShopKeep

Series B in 2012
ShopKeep is a New York-based company that provides comprehensive point of sale (POS) solutions for small and medium-sized businesses. Founded in 2008, ShopKeep offers hardware such as card readers, receipt printers, and cash drawers, along with cloud-based software for inventory management, employee tracking, customer analytics, and reporting. Its POS system runs on an iPad, supporting EMV and NFC for secure payments including Apple Pay. Additionally, ShopKeep provides merchant cash advance services, marketing tools, and integrations with third-party software providers like accounting and loyalty programs. With over 25,000 customers across the U.S., Canada, and Guam, ShopKeep's award-winning customer support is available 24/7 to assist businesses in running smarter operations.

CytomX Therapeutics

Series B in 2012
CytomX Therapeutics is a clinical-stage oncology-focused biopharmaceutical company that develops proteolytically-activated antibodies based on its Probody technology platform. Probody therapeutics are designed to be activated by the tumor microenvironment, enabling targeted cancer immunotherapies with reduced activity in healthy tissues. The company advances antibody and antibody-drug conjugate programs such as CX-072 (PD-L1), CX-2009 (CD166-targeted PDC), BMS-986249 (CTLA-4 Probody), CX-2029 (CD71-targeted PDC), and BMS-986288 (CTLA-4 Probody) in clinical research, and maintains collaborations with AbbVie, Amgen, Bristol-Myers Squibb, ImmunoGen, Pfizer, and Astellas to develop Probody therapeutics. Founded in 2008 and headquartered in South San Francisco, the company aims to improve the precision and safety of antibody-based therapies for cancer and inflammatory diseases.

Onefinestay

Series B in 2012
Onefinestay is a hospitality company that specializes in providing short-term accommodation in carefully curated boutique homes and villas. Established in London in 2009, it allows homeowners to earn extra income by renting out their properties while offering guests a unique way to experience a city. The company manages the entire process, from marketing the homes to handling bookings, ensuring a seamless rental experience for both guests and hosts. Onefinestay is committed to delivering peace of mind and convenience, featuring a dedicated support team available 24/7 for guests during their stay. With offices in major cities such as Paris, New York, and Los Angeles, Onefinestay aims to redefine the hospitality landscape by expanding its distinct category of accommodation to a global audience.

Ambra Health

Series B in 2012
Ambra Health is a medical data and image management company that provides a cloud-based platform for healthcare providers. The platform is designed to enhance imaging innovation by offering secure and easy access to medical images, facilitating internal adoption, and strengthening collaboration among healthcare organizations. With its intuitive and flexible design, Ambra's solutions enable health systems, radiology practices, and clinical research organizations to improve workflows related to imaging and patient care. The company's technology aims to make medical images and data accessible from anywhere, significantly enhancing operational efficiency and business outcomes within the healthcare sector.

SilverRail

Series B in 2012
SilverRail, established in 2009 and headquartered in London, UK, specializes in digital infrastructure for the rail industry. Its platform connects rail carriers and suppliers with travel distributors, offering a comprehensive customer experience from journey planning to ticketing. This includes inventory management, scheduling, pricing, booking, payment, and administration, facilitating seamless global rail access.

Transcend Medical

Series B in 2012
Transcend Medical, Inc. is an ophthalmic device company based in Menlo Park, California, focused on developing innovative medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005, Transcend Medical emerged from ForSight Labs, an incubator dedicated to ophthalmic innovations. The company's flagship product, the CyPass Micro-Stent, is a micro-invasive device designed to be implanted during routine cataract surgery to reduce intraocular pressure. Additionally, Transcend Medical offers the Vold Gonio Lens for use in micro-invasive glaucoma surgeries and provides clinical trial services. The CyPass Micro-Stent received its CE mark in 2008 and has been undergoing evaluation in various clinical studies, including the COMPASS multi-center trial, to assess its effectiveness and safety in treating glaucoma. As of 2016, Transcend Medical operates as a subsidiary of Alcon Holdings, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.